P271 Fecal calprotectin at diagnosis is associated with oral steroid use first year of Inflammatory Bowel Disease.

Strande, V.(1,2);Småstuen, M.C.(3,4);Huppertz-Hauss, G.(5);Perminow, G.(6);Henriksen, M.(7);Bengtson, M.B.(8);Høie, O.(9);Ricanek, P.(10);Opheim, R.(3,11);Cetinkaya, R.B.(12);Torp, R.(13);Vatn, S.(1,10);Aabrekk, T.B.(8);Detlie, T.E.(1,10);Hovde, Ø.(14,15);Høivik, M.L.(3,15);Kristensen, V.A.(2,3);

(1)University of Oslo, Faculty of Medicine, Oslo, Norway;(2)Lovisenberg Diaconal Hospital, Unger-Vetlesen Institute, Oslo, Norway;(3)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(4)Oslo Metropolitan University, Department of Public Health, Oslo, Norway;(5)Telemark Hospital, Department of Gastroenterology, Skien, Norway;(6)Oslo University Hospital, Pediatric Department, Oslo, Norway;(7)Østfold Hospital Trust, Department of Gastroenterology, Grålum, Norway;(8)Vestfold Hospital Trust, Medical Department, Tønsberg, Norway;(9)Sørlandet Hospital Arendal, Department of Internal Medicine, Arendal, Norway;(10)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(11)University of Oslo, Department of Nursing Science- Institute of Health and Society, Oslo, Norway;(12)Diakonhjemmet Hospital, Department of Medicine, Oslo, Norway;(13)Innlandet Hospital Trust, Medical Department, Hamar, Norway;(14)Innlandet Hospital Trust, Department of Medicine, Gjøvik, Norway;(15)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;